Teiko today announced an expansion of its validated antibody clone library, now spanning 120 unique markers and 170 validated clones for profiling human and NHP samples by mass cytometry and spectral flow cytometry. Every clone is validated on fixed samples—either TokuKit-fixed whole blood or PFA-fixed PBMCs—confirming performance in the same sample types used in clinical trials.
A panel optimized for fresh whole blood won't necessarily work on a fixed sample. One of the hardest parts of panel development for fixed whole blood workflows is finding an antibody clone whose epitope stays accessible after fixation. Every clone in this library has been confirmed at Teiko to bind its target on fixed whole blood and stain like fresh—so the epitope is accessible and the clone is compatible from the start.
Teams have two options:
In both cases, Teiko works alongside teams to optimize for their specific markers, assay, and instrument setup.
Across both human and NHP, the antibody library covers:
In total, that's 111 human markers for mass cytometry, 24 for spectral flow cytometry, and 44 NHP markers validated for mass cytometry in rhesus and cynomolgus monkeys.
The full validated clone library is available at teiko-labs.com/tokukit. Teams building panels for TokuKit-fixed samples can browse by marker, clone, and application to find validated options for their specific assay needs.
Learn more at teiko-labs.com/tokukit
.png)
